ArticleGastro hep advances2025

Early Endoscopic Outcomes After Risankizumab Are Associated With Fewer Hospitalizations and Surgeries in Crohn's Disease.

Brian G Feagan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.